Core Viewpoint - A total of 40 companies will have their restricted shares unlocked next week, amounting to 3.323 billion shares with a total market value of 79.774 billion yuan based on the closing price on October 10 [1] Group 1: Unlocking Schedule and Market Impact - The peak unlocking day is October 13, with 20 companies unlocking shares worth a total of 55.417 billion yuan, accounting for 69.46% of the total unlocking scale for the week [1] - The companies with the highest unlocking market value on October 10 are: China Merchants Port (11.967 billion yuan), Meihua Medical (9.804 billion yuan), and Weijie Chuangxin (8.207 billion yuan) [1] Group 2: Individual Company Unlocking Details - The companies with the largest number of unlocked shares are: China Merchants Port (577 million shares), Qingnong Commercial Bank (500 million shares), and Meihua Medical (412 million shares) [1] Group 3: Types of Restricted Shares - The types of unlocked shares include: 14 companies with original shareholders' restricted shares, 8 companies with restricted shares from directed placements, 6 companies with restricted shares from equity incentives, 5 companies with general equity incentive shares, 4 companies with original placement shares, 2 companies with original shareholders' strategic placement shares, and 1 company with strategic placement shares [1]

据统计，下周将有40只股解禁，按照最新收盘价计算，合计解禁市值819.68亿元。招商港口下周将有 5.77亿股上市流通，主要为定向增发机构配售股份，解禁市值达119.67亿元。美好医疗的解禁规模次 之，下周将有4.12亿股上市流通，解禁股主要为首发原股东限售股份，解禁市值达98.04亿元。解禁比例 来看，美好医疗、安达智能、可川科技、冠龙节能等8股的解禁比例居前，均超50%。（证券时报） ...

证券日报网讯 10月10日晚间，美好医疗发布公告称，经与会职工代表认真审议与民主选举，一致同意 选举周道福先生为公司第二届董事会职工代表董事。 （文章来源：证券日报） ...

证券代码：301363 证券简称：美好医疗 公告编号：2025-066 深圳市美好创亿医疗科技股份有限公司 关于董事辞任暨选举职工代表董事的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事辞任情况 深圳市美好创亿医疗科技股份有限公司（以下简称"公司"）于近日收到公 司董事周道福先生的书面辞职报告。因工作安排原因，周道福先生申请辞去公司 非独立董事职务。周道福先生辞任后将继续担任公司副总经理职务，周道福先生 的辞任不会导致公司董事会人数低于法定最低人数，不存在应履行而未履行的公 开承诺，其书面辞职报告自送达公司董事会之日起生效。 二、选举职工代表董事情况 根据《中华人民共和国公司法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《公司章程》等相关规定，公司于2025年10 月10日召开了职工代表大会。经与会职工代表认真审议与民主选举，一致同意选 举周道福先生（简历附后）为公司第二届董事会职工代表董事，任期至第二届董 事会届满之日止。 周道福先生原为公司第二届董事会非职工代表董事，变更为第二届董事会职 工代表董事后，公司第 ...

证券代码：301363 证券简称：美好医疗 公告编号：2025-065 深圳市美好创亿医疗科技股份有限公司 2025年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会未出现变更或否决议案的情形； 2、本次股东会不涉及变更前次股东会决议； 3、本次股东会采用现场表决与网络投票相结合的方式召开。 一、会议召开和出席情况 深圳市美好创亿医疗科技股份有限公司（以下简称"公司"）2025年第二次 临时股东会（以下简称"本次股东会"）于2025年10月9日（星期四）15:00召开， 公司已于2025年9月16日披露了《关于召开2025年第二次临时股东会的通知》（公 告编号：2025-064），具体内容详见公司在巨潮资讯网（www.cninfo.com.cn） 上披露的相关公告。本次股东会采用现场投票和网络投票相结合的方式召开，会 议有关事项具体如下： 1、现场会议召开时间：2025年10月9日（星期四）15:00 2、现场会议召开地点：广东省惠州市大亚湾西区龙山三路318号美好创亿产 业园A栋8楼801会议室 3、网络投 ...

法律意见书 中国 深圳 福田区 益田路6001号太平金融大厦11、12楼 邮政编码：518038 11F/12F., Taiping Finance Tower, 6001 Yitian Road, Futian District, Shenzhen, P.R. China 518038 电话(Tel.)：（0755）8826 5288 传真（Fax.）：（0755）8826 5537 网址（Website）：https://www.sundiallawfirm.com 广东信达律师事务所 关于深圳市美好创亿医疗科技股份有限公司 2025 年第二次临时股东会的 法律意见书 信达会字（2025）第 314 号 致：深圳市美好创亿医疗科技股份有限公司 广东信达律师事务所（以下简称"信达"）接受深圳市美好创亿医疗科技股 份有限公司（以下简称"贵公司"）的委托，指派律师参加了贵公司二〇二五年 第二次临时股东会（以下简称"本次临时股东会"），并进行了必要的验证工作。 现根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司股 东会规则》（以下简称"《股东会规则》"）以及贵公司《公司章程》的规定， 按照律师业 ...

Investment Rating - The industry rating is "Positive" (maintained) [7] Core Views - The report highlights that the domestic innovative drug sector is entering a phase of "engineer dividend" realization, with improved profitability and valuation breakthroughs expected [1] - The CXO sector is showing signs of recovery, with a positive outlook on CDMO commercialization orders and clinical CRO investment opportunities [2] - The upstream research sector is anticipated to benefit from a downward interest rate cycle and a recovery in global new drug development demand, with recommended stocks including Haoyuan Pharmaceutical and Bid Pharma [3] - The medical device sector is expected to experience a recovery cycle, particularly for high-value consumables and medical equipment companies, with recommendations for companies like Aikang Medical and Mindray Medical [4] - The traditional Chinese medicine sector is projected to see an earnings inflection point, with a favorable outlook for the second half of 2025 [5] - The report favors leading pharmacy chains with superior management capabilities, recommending companies such as Dazhonglin and Yifeng Pharmacy [6] - The pharmaceutical distribution sector is expected to improve, with a focus on low-positioned value and innovative business opportunities [7] Summary by Sections Innovative Drugs - Positive outlook on profitability improvement and valuation breakthroughs due to recognition by multinational corporations [1] CXO - Recovery in the sector with ongoing commercialization of small and large molecule CDMO orders [2] Upstream Research - Anticipated performance elasticity and new business expansion opportunities [3] Medical Devices - Significant growth potential in high-value consumables and medical equipment sectors [4] Traditional Chinese Medicine - Expected earnings growth and increased market interest due to improved fundamentals [5] Pharmacies - Favorable view on pharmacy chains with strong management and adaptability [6] Pharmaceutical Distribution - Positive trends in the sector with potential for operational improvements and value re-evaluation [7]

Market Performance - On October 1, U.S. stock markets initially dropped due to the government shutdown but later rebounded, with the Dow Jones index rising 0.09% to a record high, the S&P 500 increasing by 0.34%, and the Nasdaq Composite gaining 0.42% [1] - Chinese assets strengthened, with the Nasdaq Golden Dragon China Index up 1.44%. Most popular Chinese concept stocks saw gains, including Vipshop up 5.36%, Baidu up 4.3%, JD.com up 3.4%, Alibaba up 2.25%, Pinduoduo up 1.69%, Xpeng up 1.11%, and Li Auto up 0.63% [1] Stock Unlocking Events - In October, 107 stocks are facing unlocking events, with a total market value of 240.73 billion yuan based on the latest closing prices, indicating lower unlocking pressure compared to July, August, and September [2] - Three stocks have unlocking values exceeding 10 billion yuan: China Merchants Port with 577 million shares unlocking, valued at 11.546 billion yuan; Meihua Medical with 412 million shares unlocking, valued at 10.324 billion yuan; and Hengshuai Co. [2][3] Unlocking Ratios and Performance - 25 stocks have unlocking ratios exceeding 50%, with seven stocks, including Arrow Home, Ousheng Electric, Sanbai Shuo, and Meino Energy, having ratios above 70% [4] - Conversely, 24 stocks, including Shengquan Group and Baoding Technology, have relatively low unlocking pressure, with unlocking values below 10 million yuan [7] Performance of Unlocking Stocks - Among the unlocking stocks, 22 reported losses in the first half of the year. The average stock price of unlocking stocks increased by 2.84% since September [8] - Demingli saw the highest price increase, with a 117.02% rise since September, while Zhongke Jincai experienced the largest decline, down 29.55% [8] Institutional Research and Future Prospects - 20 unlocking stocks were researched by institutions in September, with 14 stocks having more than 10 institutional inquiries. Ruide Intelligent received 50 inquiries and has a market value of 5.97 billion yuan facing unlocking [9] - Future growth areas for Ruide include pet technology, healthcare, low-altitude flight, smart home, and robotics, while Fuchuang Precision, with 44 institutional inquiries, has a market value of 9.582 billion yuan facing unlocking [9]

Market Performance - On October 1, U.S. stock markets initially dropped due to the government shutdown but later rebounded, with the Dow Jones index closing up 0.09%, reaching a historical high [1] - The S&P 500 index increased by 0.34%, and the Nasdaq Composite index rose by 0.42% [1] Chinese Stocks - The Nasdaq China Golden Dragon Index rose by 1.44%, with most popular Chinese concept stocks experiencing gains [3] - Notable stock performances include Vipshop up 5.36%, Baidu up 4.3%, JD.com up 3.4%, Alibaba up 2.25%, Pinduoduo up 1.69%, Xpeng Motors up 1.11%, and Li Auto up 0.63% [3] Stock Unlocking Events - In October, 107 stocks are facing unlocking events, with a total market value of 240.73 billion yuan, which is lower than the unlocking pressure in July, August, and September [4] - Three stocks have unlocking values exceeding 10 billion yuan: China Merchants Port (11.55 billion yuan), Meihua Medical (10.32 billion yuan), and Hengshuai Co. (10.31 billion yuan) [6] Performance of Unlocking Stocks - Among the unlocking stocks, 22 reported losses in the first half of the year, with notable declines in companies like Dizh Medical-U and Baiwei Storage [11] - The average stock price of unlocking stocks increased by 2.84% since September, with Demingli leading with a 117.02% increase [10] Institutional Research - 20 unlocking stocks were researched by institutions in September, with 14 stocks having more than 10 institutional inquiries [11] - Companies like Ruide Intelligent and Fuchuang Precision received significant attention, with Ruide Intelligent focusing on the pet economy and Fuchuang Precision achieving breakthroughs in heating plate technology [11]

Group 1 - In October, a total of 107 stocks are facing lock-up expiration, with a market value of 240.728 billion yuan, which is lower than the lock-up pressure in July, August, and September [2] - Among the stocks facing lock-up expiration, three have a market value exceeding 10 billion yuan: China Merchants Port (001872) with 11.546 billion yuan, Meihua Medical (301363) with 10.324 billion yuan, and Hengshuai Co., Ltd. (300969) [2] - 25 stocks have a lock-up ratio exceeding 50%, with seven stocks having a lock-up ratio over 70%, indicating significant potential selling pressure [2] Group 2 - The average stock price of the lock-up stocks has increased by 2.84% since September, with Demingli (001309) leading with a 117.02% increase [3] - 22 stocks facing lock-up expiration reported losses in the first half of the year, with Dize Pharmaceutical-U showing the largest loss of 3.77 billion yuan [5] - Companies like Ruide Intelligent (301135) and Fuchuang Precision have received significant institutional research attention, indicating potential investor interest despite upcoming lock-up expirations [4]